المؤلفون: Saturno, G., Lopes, F., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Lee, R., Viros, A., Holovanchuk, D., Pedersen, M., McLeary, R., Lorigan, P., Dhomen, N., Fisher, C., Banerji, U., Dean, E., Krebs, M. G., Gore, M., Larkin, J., Marais, R., Springer, C.

المساهمون: Saturno, G., Lopes, F., Niculescu-Duvaz, I., Niculescu-Duvaz, D., Zambon, A., Davies, L., Johnson, L., Preece, N., Lee, R., Viros, A., Holovanchuk, D., Pedersen, M., Mcleary, R., Lorigan, P., Dhomen, N., Fisher, C., Banerji, U., Dean, E., Krebs, M. G., Gore, M., Larkin, J., Marais, R., Springer, C.

مصطلحات موضوعية: CRC, KRAS, NSCLC, panRAF/SRC inhibitor, PDAC

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33130216; info:eu-repo/semantics/altIdentifier/wos/WOS:000608030000017; volume:32; issue:2; firstpage:269; lastpage:278; numberofpages:10; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11380/1215608Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85098875008

الإتاحة: https://doi.org/10.1016/j.annonc.2020.10.483Test
http://hdl.handle.net/11380/1215608Test

المؤلفون: Richard Marais, Grazia Saturno, Robert McLeary, Cyril Fisher, Udai Banerji, Alfonso Zambon, Lawrence Davies, Rebecca Lee, J.M.G. Larkin, Natasha Preece, Emma Dean, Paul Lorigan, Dan Niculescu-Duvaz, Matthew G Krebs, Amaya Viros, Nathalie Dhomen, Malin Pedersen, L. Johnson, Filipa Lopes, Caroline J. Springer, D. Holovanchuk, M. E. Gore, Ion Niculescu-Duvaz

المصدر: Annals of Oncology
Saturno, G, Lopes, F, Niculescu-Duvaz, I, Niculescu-Duvaz, D, Zambon, A, Davies, L, Johnson, L, Preece, N, Lee, R, Viros Usandizaga, A, Holovanchuk, D, Pedersen, M, Mcleary, R, Lorigan, P, Dhomen, N, Fisher, C, Banerji, U, Dean, E, Krebs, M, Gore, M, Larkin, J, Marais, R & Springer, C 2021, ' The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers ', Annals of Oncology, vol. 32, no. 2, pp. 269-278 . https://doi.org/10.1016/j.annonc.2020.10.483Test

مصطلحات موضوعية: 0301 basic medicine, Drug, Lung Neoplasms, media_common.quotation_subject, Phases of clinical research, medicine.disease_cause, NSCLC, CRC, KRAS, panRAF/SRC inhibitor, PDAC, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Mice, 0302 clinical medicine, Pancreatic tumor, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Medicine, Animals, Humans, Src family kinase, Protein Kinase Inhibitors, media_common, Cell Proliferation, business.industry, Kinase, Hematology, medicine.disease, digestive system diseases, 030104 developmental biology, src-Family Kinases, Oncology, 030220 oncology & carcinogenesis, Mutation, Cancer research, Original Article, Spindle cell sarcoma, business, Proto-oncogene tyrosine-protein kinase Src

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9dd4c81e95c2a5d81da34368a411222Test
http://europepmc.org/articles/PMC7839839Test